NeuroDerm
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NeuroDerm and buy or sell other stocks, ETFs, and their options commission-free!About NDRM
NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders.
CEOKengo Isshiki
CEOKengo Isshiki
Employees—
Employees—
HeadquartersRehovot, HaMerkaz
HeadquartersRehovot, HaMerkaz
Founded2003
Founded2003
Employees—
Employees—
NDRM Key Statistics
Market cap1.02B
Market cap1.02B
Price-Earnings ratio-19.62
Price-Earnings ratio-19.62
Dividend yield—
Dividend yield—
Average volume214.09K
Average volume214.09K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$38.95
52 Week high$38.95
52 Week low$15.20
52 Week low$15.20
Stock Snapshot
With a market cap of 1.02B, NeuroDerm(NDRM) trades at $38.85. The stock has a price-to-earnings ratio of -19.62.
During the trading day, NeuroDerm(NDRM) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for NeuroDerm(NDRM) stock has reached 0, versus its average volume of 214.09K.
The stock's 52-week range extends from a low of $15.20 to a high of $38.95.
The stock's 52-week range extends from a low of $15.20 to a high of $38.95.